N/A
N=325
Preventing the Spread of Infection in Nursing Homes
Staphylococcus Aureus
Bottom Line
View on ClinicalTrials.gov: NCT03319368 ↗Enrolled (actual)
325
Serious AEs
17.2%
Results posted
Mar 2024
Primary outcome: Primary: Rates of Staphylococcus Aureus Acquisition: Percentage of Short Stay Participants Who Acquired MRSA or MSSA (or Both) During the Study Period — 17; 8 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Targeted gown and glove use (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Maryland, Baltimore
- Primary completion
- Jul 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Rates of Staphylococcus Aureus Acquisition: Percentage of Short Stay Participants Who Acquired MRSA or MSSA (or Both) During the Study Period |
17; 8 | — |
| SECONDARY Rates of Staphylococcus Aureus Transmission: Percentage of Short Stay Participants Who Acquired MRSA or MSSA (or Both) From MRSA/MSSA Transmission From Another Study Participant During the Study Period |
6; 1 | — |
Summary
This study evaluates the feasibility of targeting more frequent gown and glove use for specific high risk moments of care in specific nursing home residents in order to prevent Staphylococcus aureus (SA) acquisition and infection.
Eligibility Criteria
Inclusion Criteria
- Age ≥18 years
- Reside in a participating nursing home
Exclusion Criteria
- Identified by nursing home staff as combative or with other behavioral problems which could lead to agitation if approached by project staff
Data sourced from ClinicalTrials.gov (NCT03319368). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.